PNC Financial Services Group’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-67	Closed	-$1.38K	–	4800
2024 Q2	$1.38K	Buy	67 +60	+857%	+$1.23K	﹤0.01%	4355
2024 Q1	$302	Sell	7 -52	-88%	-$2.24K	﹤0.01%	4553
2023 Q4	$2.76K	Buy	+59	New	+$2.76K	﹤0.01%	4112